Top compounds associated with response to NPR2


Feature Type Standardized
Nominal ANOVA
mRNA fingolimod CTRPv2 pan-cancer AAC -0.073 0.05
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.072 0.05
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.062 0.05
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.071 0.05
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.06
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.071 0.06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.06
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.071 0.06
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.06
Download CSV